[1]Patent:WO2018/204416,2018,A1.Locationinpatent:Paragraph00334
[2]Patent:WO2019/212991,2019,A1.Locationinpatent:Paragraph00438
[1]Patent:WO2019/212991,2019,A1.Locationinpatent:Paragraph00438
Title: Discovery of potent and selective inhibitors of the mammalian target of rapamycin (mTOR) kinase.
Journal: Journal of medicinal chemistry 20091126
Title: Yu K, et al. Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin. Cancer Res. 2009 Aug 1;69(15):6232-40.
Title: Wang K, et al. MEK-ERK inhibition potentiates WAY-600-induced anti-cancer efficiency in preclinical hepatocellular carcinoma (HCC) models. Biochem Biophys Res Commun. 2016 May 27;474(2):330-7.